Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06628258
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-14
Brief Title:
A Clinical Study to Assess the Safety and Effectiveness of Test Product Moiz Cleansing Lotion in Healthy Adult Human Subjects With Varied Skin Types Dry Oily Sensitive Mixed Normal
Sponsor:
None
Organization:
None
Study Overview
Official Title:
An Exploratory Prospective Open-Label Interventional Safety In-Use Tolerability and Efficacy Study of Test Product Moiz Cleansing Lotion in Healthy Human Subjects
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is an exploratory prospective open-label interventional safety in-use tolerability and efficacy study of the test product Moiz Cleansing Lotion in healthy human subjects
Detailed Description:
27 subjects with different skin type dry oily sensitive mixed of either gender aged between 18 to 65 years old both inclusive at time consent will be enrolled to complete 25 subjectstest product in the study
The potential subjects will be screened as per the inclusion exclusion criteria only after obtaining written informed consent from the subjects Subjects will be pre-screened by the screening department of NovoBliss Research Subjects will be called telephonically by the recruiting department prior to the enrolment visit Subjects will be told during screening prior to enrolment not to wear any facial make-up on the study visit day The adult female subjects will be instructed to visit the facility as per the below visits-
Visit 01 Day 01 Screening Enrolment Baseline Evaluation On Site Product Usage Post Usage Evaluation
Visit 02 Day 15 2 Days Product Usage Period Evaluations
Visit 03 Day 30 2 Days Evaluations End of Study
The potential subjects will be screened as per the inclusion exclusion criteria only after obtaining written informed consent from the subjects Subjects will be pre-screened by the screening department of NovoBliss Research Subjects will be called telephonically by the recruiting department prior to the enrolment visit Subjects will be told during screening prior to enrolment not to wear any facial make-up on the study visit day The adult female subjects will be instructed to visit the facility as per the below visits-
Visit 01 Day 01 Screening Enrolment Baseline Evaluation On Site Product Usage Post Usage Evaluation
Visit 02 Day 15 2 Days Product Usage Period Evaluations
Visit 03 Day 30 2 Days Evaluations End of Study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None